Welltower stock: UBS keeps USD 269 target for Welltower stock

Published on 10/21/2026 at 15:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Welltower reports third-quarter results on October 26, 2026. Welltower stock costs EUR 212.05 on October 21, 2026 at 3:33 p.m. CEST.

Analyst and earnings dates

UBS maintained a USD 269.00 target and Buy rating on October 13, 2026.
Welltower will report third-quarter 2026 results on October 26, 2026.
Welltower stock costs EUR 212.05 at Lang & Schwarz on October 21, 2026 at 3:33 p.m. CEST.

Architektur-Render eines modernen Gesundheitsgebäudes für Welltower Inc. mit Glasfassade — Welltower Inc. (US95040Q1040) entwickelt hochwertige Gesundheitsimmobilien, hier visualisiert als modernes, glänzendes Architektur-Render bei Tageslicht, Illustration mit AI erstellt.

UBS maintained its Buy rating and USD 269.00 price target for Welltower on October 13, 2026, leaving the target 12.70 percent above the USD 238.69 NYSE price on October 21, 2026. Gekko lists the UBS action alongside a Buy rating. Welltower was trading at EUR 212.05 at Lang & Schwarz on October 21, 2026 at 3:33 p.m. CEST.

Results arrive October 26

Welltower is scheduled to release third-quarter 2026 results after the New York Stock Exchange close on October 26, 2026, followed by a conference call on October 27 at 9:00 a.m. ET. MarketScreener reports that the company announced the schedule on September 23, 2026.

Second-quarter growth sets the baseline

For the second quarter of 2026, revenue reached USD 3.54 billion, up 39.10 percent from the prior-year quarter, while diluted earnings per share came to USD 0.61. Revenue exceeded the USD 3.40 billion consensus estimate, but earnings per share missed the USD 0.66 consensus estimate. MarketBeat published those figures on October 20, 2026 and said full-year 2026 earnings guidance stood at USD 6.36 to USD 6.44 per share.

Price position and valuation

The NYSE quote was USD 238.69 on October 21, 2026 at 9:38 a.m. EDT. Welltower's 52-week range was USD 174.72 to USD 255.20, putting the current price 6.47 percent below the high and 36.61 percent above the low. Market capitalization was USD 172.0 billion on the same date.

Comparison with peers

Welltower: market capitalization USD 172.0 billion, P/E 107.15. Ventas (NYSE, USD): up 0.25 percent, P/E 160.40, market capitalization USD 44.5 billion. Omega Healthcare Investors (NYSE, USD): down 0.13 percent, P/E 16.30, market capitalization USD 13.8 billion. The comparison places Welltower's valuation multiple well above Omega's and below Ventas's, while its market value is larger than either peer.

What comes next for investors

The October 26 release will test whether the second-quarter revenue expansion and the stated earnings guidance remain intact. The analyst target provides a separate valuation reference, but it is denominated in USD and is not a forecast made by this article.

Welltower stock in trading

Welltower was trading at EUR 212.05 at Lang & Schwarz on October 21, 2026 at 3:33 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Welltower stock.